GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (BOM:543635) » Definitions » Accounts Receivable

Piramal Pharma (BOM:543635) Accounts Receivable : ₹21,344 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Piramal Pharma's accounts receivables for the quarter that ended in Mar. 2024 was ₹21,344 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Piramal Pharma's Days Sales Outstanding for the quarter that ended in Mar. 2024 was 76.31.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Piramal Pharma's Net-Net Working Capital per share for the quarter that ended in Mar. 2024 was ₹-30.87.


Piramal Pharma Accounts Receivable Historical Data

The historical data trend for Piramal Pharma's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Accounts Receivable Chart

Piramal Pharma Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Accounts Receivable
8,397.50 17,852.80 17,993.40 21,344.30

Piramal Pharma Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17,993.40 - 17,433.80 - 21,344.30

Piramal Pharma Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Piramal Pharma Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Piramal Pharma's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=21344.3/25523.6*91
=76.31

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Piramal Pharma's accounts receivable are only considered to be worth 75% of book value:

Piramal Pharma's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2024 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(6431.4+0.75 * 21344.3+0.5 * 21758.8-74004.4
-0-0)/1318.02
=-30.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Piramal Pharma Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Piramal Pharma (BOM:543635) Business Description

Traded in Other Exchanges
Address
Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070
Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (BOM:543635) Headlines

No Headlines